Apolipoprotein A-I(FIN) (Leu159→Arg) mutation affects lecithin: Cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 3021-3032

  Miettinen, Helena E ^a   Jauhiainen, Matti ^b   Gylling, Helena ^a   Ehnholm, Sonja ^b   Palomäki, Ari ^c   Miettinen, Tatu A ^a   Kontula, Kimmo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Department of Cardiology   (Finland)

Author keywords

Apolipoprotein A I kinetics; Coronary artery disease; HDL; Mutation; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; PROTEOLIPID; PROTEOLIPOSOMES;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; KINETICS; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEOLIPOSOME; ADOLESCENT; AGED; CLASSIFICATION; FIBROBLAST; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; PARTICLE SIZE; PEDIGREE; POINT MUTATION;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEIN A-I; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PARTICLE SIZE; PEDIGREE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; POINT MUTATION; PROTEOLIPIDS;

EID: 0031283268     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.3021     Document Type: Article

References (5)

1. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
2. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589-597.
3. Barter PJ, Rye K-A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
4. Stein O, Fainaru M, Stein Y. The role of lysophosphatidylcholine and apolipoprotein Al in the cholesterol-removing capacity of lipoprotein-deficient serum in tissue culture. Biochim Biophys Acta. 1979;574:495-504.
5. Bielicki JK, Johnson WJ, Weinberg RB, Blick JM, Rothblat GH. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res. 1992;33:1699-1709.